Comprehensive Genomic Profiling

The AJMC® Comprehensive Genomic Profiling compendium is a comprehensive resource for clinical news and expert insights for the next-generation sequencing approach to assess genes for the purpose of therapy guidance.

Dr Patricia Deverka Addresses Potential Disparities in Multicancer Early Detection Tests

June 10th 2022, 3:15pm

Video

Providing insurance coverage for multicancer early detection (MCED) tests is vital to reduce disparities in access, said Patricia Deverka, MD, MS, senior researcher, deputy director at the Center for Translational and Policy Research and Precision Medicine, University of California San Francisco.

NPC's Michael Ciarametaro Lists 3 Ways the Gene Therapy Market Addresses Value-Based Contract Concerns

June 3rd 2022, 5:12pm

Video

Michael Ciarametaro, MBA, vice president of research at the National Pharmaceutical Council (NPC), explains the ways that the gene therapy market is working to address concerns regarding contractual riders for value-based contracts for expensive therapies.

Contributor: The Case for Education and Clinical Decision Support With Pharmacogenetics

June 2nd 2022, 6:40pm

Article

Prescribing is a complex process with multiple factors to consider on top of the 3 primary questions about effectiveness, harm, and cost. Pharmacogenetics has put this complexity under the spotlight and prompted educational programs and the development of new clinical decision support systems.

As Number of Targeted Therapies Increases, Challenges With Precision Medicine Are Not Going Away

May 24th 2022, 5:31pm

Article

There are an increasing number of targeted therapies in oncology, but challenges around biomarker testing and treatment selection remain.

Dr Patricia Deverka on Determining Value of Multicancer Detection Tests

May 20th 2022, 7:45pm

Video

The value of multicancer early detection tests is based not only on cost, but cost in relation to the outcomes, said Patricia Deverka, MD, MS, senior researcher, deputy director at the Center for Translational and Policy Research and Precision Medicine, University of California San Francisco.

Contributor: The Convergence of Value-Based Care and Lab Testing Growth

May 17th 2022, 5:15pm

Article

Today, health plans are shifting dollars to more value-based contracts along with investments in population health management. Digitizing lab results across all care settings and unlocking the potential of lab values can help health plans reach the Triple Aim of improving the patient experience, improving the health of populations, and reducing the per-member cost of health care.

Dr Patricia Deverka Explains Next Steps Toward Medicare Coverage of Multicancer Early Detection Tests

May 13th 2022, 7:15pm

Video

The US Preventive Services Task Force has never evaluated a multicancer screening test for endorsement, which may make the process even longer, said Patricia Deverka, MD, MS, senior researcher, deputy director at the Center for Translational and Policy Research and Precision Medicine, University of California San Francisco.

Assessing Cost Savings, Waste Reduction From Pharmacogenomics and Precision Medicine

May 11th 2022, 8:47pm

Article

David Skomo, and Nick Page, PharmD, of WellDyne offered their perspectives on recent developments in precision medicine at the 2022 Asembia Specialty Pharmacy Summit.

Next-Generation Sequencing Finds Different Molecular Profiles of Pediatric, Adult Sarcomas

May 7th 2022, 5:20pm

Article

Next-generation sequencing identified different molecular profiles of pediatric and adult sarcomas among Chinese patients.

Dr Sneha Sharma Discusses the Growing Roles of Biomarker Testing, Biosimilars

May 5th 2022, 12:28pm

Video

Biomarker testing is having growing importance to ensure that patients are started on the correct therapy for the best outcomes, said Sneha Sharma, PharmD, director, specialty clinical solutions, Magellan Rx.